- Home
- IMAX vs RLAY Comparison
IMAX vs RLAY Comparison
Compare IMAX & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAX
- RLAY
- Stock Information
- Founded
- IMAX 1967
- RLAY 2015
- Country
- IMAX Canada
- RLAY United States
- Employees
- IMAX N/A
- RLAY N/A
- Industry
- IMAX
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMAX
- RLAY Health Care
- Exchange
- IMAX Nasdaq
- RLAY Nasdaq
- Market Cap
- IMAX 1.3B
- RLAY 1.1B
- IPO Year
- IMAX 1994
- RLAY 2020
- Fundamental
- Price
- IMAX $24.70
- RLAY $4.64
- Analyst Decision
- IMAX Buy
- RLAY Strong Buy
- Analyst Count
- IMAX 10
- RLAY 9
- Target Price
- IMAX $24.50
- RLAY $20.88
- AVG Volume (30 Days)
- IMAX 731.9K
- RLAY 1.4M
- Earning Date
- IMAX 10-30-2024
- RLAY 11-06-2024
- Dividend Yield
- IMAX N/A
- RLAY N/A
- EPS Growth
- IMAX N/A
- RLAY N/A
- EPS
- IMAX 0.44
- RLAY N/A
- Revenue
- IMAX $345,554,000.00
- RLAY $10,006,000.00
- Revenue This Year
- IMAX $3.13
- RLAY N/A
- Revenue Next Year
- IMAX $9.71
- RLAY N/A
- P/E Ratio
- IMAX $56.35
- RLAY N/A
- Revenue Growth
- IMAX N/A
- RLAY N/A
- 52 Week Low
- IMAX $13.20
- RLAY $4.48
- 52 Week High
- IMAX $25.28
- RLAY $12.14
- Technical
- Relative Strength Index (RSI)
- IMAX 65.90
- RLAY 23.64
- Support Level
- IMAX $24.08
- RLAY $5.96
- Resistance Level
- IMAX $25.15
- RLAY $6.39
- Average True Range (ATR)
- IMAX 0.63
- RLAY 0.34
- MACD
- IMAX -0.04
- RLAY -0.12
- Stochastic Oscillator
- IMAX 56.01
- RLAY 7.92
About IMAX Imax Corporation
Imax Corp is a premier global technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers a unique end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. Top filmmakers, movie studios, artists, and creators utilize the cutting-edge visual and sound technology of IMAX to connect with audiences in innovative ways. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).